BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results

  May 7, 2025

   · 

  10 min read
• Press Releases

  Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

  May 7, 2025

   · 

  3 min read
• Press Releases

  Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain following ocular surgery

  May 7, 2025

   · 

  3 min read
• Press Releases

  Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema

  May 7, 2025

   · 

  9 min read
• Press Releases

  BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

  May 7, 2025

   · 

  4 min read
• Press Releases

  IRLAB Publishes Interim Report for the Period January - March 2025

  May 7, 2025

   · 

  9 min read
• Press Releases

  Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

  May 7, 2025

   · 

  24 min read
• Press Releases

  Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025

  May 7, 2025

   · 

  8 min read
• Press Releases

  Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

  May 7, 2025

   · 

  5 min read
• Press Releases

  Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases

  May 7, 2025

   · 

  6 min read